Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$535K Sell
269
-9,942
-97% -$15.8M ﹤0.01% 647
2026
Q1
$13.5M Sell
10,211
-11,429
-53% -$15.7M 0.1% 259
2025
Q4
$23.2M Buy
21,640
+9,054
+72% +$9.44M 0.17% 185
2025
Q3
$12.2M Buy
+12,586
New +$9.89M 0.09% 269
2025
Q1
Sell
-20,974
Closed -$14.5M 587
2024
Q4
$14.5M Buy
+20,974
New +$15.1M 0.18% 169

Other funds holding ASML

Freestone Grove Partners's ASML Position: Q2 2026 in Review

Freestone Grove Partners reduced its ASML (ASML) stake by 97% in Q2 2026, selling an estimated $15.8M and leaving 269 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Freestone Grove Partners first reported a position in ASML in Q4 2024 and has held it in 5 quarters since. The position peaked at $23.2M in Q4 2025. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Freestone Grove Partners held 269 shares of ASML worth $535K as of Q2 2026.
  • Freestone Grove Partners sold 9,942 ASML shares in Q2 2026, an estimated $15.8M.
  • ASML made up ﹤0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #647 holding.
  • Freestone Grove Partners first reported a position in ASML in Q4 2024 and has held it in 5 quarters since.
  • Freestone Grove Partners's ASML position peaked at $23.2M in Q4 2025.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.